Clinical Trials · NCT04189848
Comparison of Injection Site Pain Experience for Semaglutide and Dulaglutide sc
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 104
- Start date
- Dec 2019
- Locations
- 1 site, Netherlands
- Primary endpoint
- Intensity of Injection Site Pain